Threadneedle's Ann Berry reveals her 'stock spying' method
Threadneedle Ventures founder Ann Berry discusses the future of the IPO market and reveals how she picks her entry point when buying a stock on 'Making Money.'
Charles Payne: Economists need to stop gaslighting the public
'Making Money' host Charles Payne shows how inflation is affecting regular Americans.
Stock market isn't anywhere near a tech bubble: Jack Ablin
Cresset Chief Investment Officer and founding partner Jack Ablin discusses the biggest risks facing investors and whether the Fed will cut rates on 'Making Money.'
S&P 500 target will likely rise higher after Q1 earnings: Art Hogan
B. Riley Wealth Management chief market strategist Art Hogan discusses how he expects the economy to move in the second half of 2024 on 'Making Money.'
March jobs report showed some problematic trends: Joanie Bily
Employbridge’s Joanie Bily explains what the March jobs report says about the state of the U.S. economy on 'Making Money.'
US economy doesn't need the Fed to cut rates: Phil Camporeale
J.P. Morgan Asset Management Portfolio Manager Phil Camporeale analyzes the labor market after the hot March jobs report on 'Making Money.'
Charles Payne: Encouraging illegal immigration will never be part of America's ethos
'Making Money' host Charles Payne addresses the claim that illegal immigration has been great for the job market.
Fed June rate cut might be the only one Wall Street gets in 2024: Erika Najarian
UBS U.S. large-cap banks analyst Erika Najarian discusses the health of the banking sector and reveals which regionals are worth buying on 'Making Money.'
Charles Payne: Government data has lost a ton of credibility
'Making Money' host Charles Payne shares his thoughts on the job market and the Federal Reserve on 'Making Money.'
Stock market is climbing Wall Street's 'wall of worry': Savita Subramanian
BofA Securities head of U.S. equity and quantitative strategy Savita Subramanian explains her 'bullish' market outlook for the rest of 2024 on 'Making Money.'
Fed balance sheet is still way too big: Nancy Davis
Quadratic Capital Management founder Nancy Davis explains the concept of asymmetric risk and weighs in on the Fed's inflation battle on 'Making Money.'
Charles Payne: Jobs market is nowhere near as strong as economists say
'Making Money' host Charles Payne argues the financial media has already 'written their scripts' for Friday's jobs report.
Fed should leave interest rates right where they are: Kenny Polcari
SlateStone Wealth chief market strategist Kenny Polcari explains how investors can take advantage of wild market swings on 'Making Money.'
Custodia Bank is on the frontlines of the war against 'debanking': Caitlin Long
Custodia Bank founder and CEO Caitlin Long vows to appeal after a federal judge dismissed Custodia Bank's claim for entitlement to a Federal Reserve master account on 'Making Money.'
Jerome Powell seems ready to let the US economy run hot: Nicole Webb
Wealth Enhancement Group Senior Vice President Nicole Webb discusses whether the stock market rally is beholden to Fed rate cuts on 'Making Money.'
Bitcoin halving returns will not happen overnight: Anthony Pompliano
Pomp Investments investor Anthony Pompliano discusses the 'through-the-roof' demand for Bitcoin ETFs on 'Making Money.'
Charles Payne: What happened to America's STEM workers?
'Making Money' host Charles Payne discusses why the U.S. isn't training workers for tech or manual labor jobs.
Fed will have a problem marketing rate cuts thanks to 'sticky' inflation: Joe LaVorgna
Former White House chief economist Joe LaVorgna and JP Morgan's Kelsey Berro discuss whether strong consumer spending is a concern for the Fed on 'Making Money.'
AI trade is alive, but will take time to broaden out: Ayesha Tariq
MacroVisor co-founder Ayesha Tariq discusses whether there is anything that can disrupt this stock market rally on 'Making Money.'
Bernie Sanders doesn't know what Ozempic should cost, he just wants government to control it: Scott Martin
Kingsview Wealth Management CIO Scott Martin reacts to Sen. Bernie Sanders demanding pharmaceutical company Novo Nordisk lower the price of Ozempic on 'Making Money.'



















